Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001070081-17-000100
Filing Date
2017-06-06
Accepted
2017-06-06 18:17:12
Documents
2
Period of Report
2017-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_149678741667621.html 3  
1 FORM 3 wf-form3_149678741667621.xml 3 12402
2 POWER OF ATTORNEY - UTTER ex-24.htm EX-24 4076
  Complete submission text file 0001070081-17-000100.txt   17961
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Utter Christine Marie (Reporting) CIK: 0001707685 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35969 | Film No.: 17895203